RocketTickers

RocketTickers

AQST: Aquestive Therapeutics, Inc. 2021-10-25 08:31:00 Aquestive Therapeutics Reports Positive Topline Data from Phase 1 Pharmacokinetic Trial of AQST-109 (epinephrine prodrug sublingual film) Supporting its Development as an Oral Alternative to Epinephrine Autoinjectors for the Emergency Treatment of Allergi

RocketTickers

ALKS: Alkermes plc 2021-10-25 07:00:00 Alkermes Receives FDA Fast Track Designation for Nemvaleukin Alfa in Combination With Pembrolizumab for the Treatment of Platinum-Resistant Ovarian Cancer

RocketTickers

ZLAB,ETTX: Zai Lab Limited 2021-10-19 09:00:00 Zai Lab and Entasis Therapeutics Announce Positive Topline Results for Sulbactam-Durlobactam (SUL-DUR) from Phase 3 ATTACK Trial

RocketTickers

RDUS: Radius Health Inc. 2021-10-18 08:30:00 Radius Announces Positive Phase 3 Topline Results for TYMLOS® (abaloparatide) Subcutaneous Injection in Males with Osteoporosis

RocketTickers

MYOV: Enzyvant 2021-10-09 20:09:51 Enzyvant Receives FDA Approval for RETHYMIC® (allogeneic processed thymus tissue-agdc), a One-Time Regenerative Tissue-Based Therapy for Pediatric Congenital Athymia

RocketTickers

RXRX: Recursion Pharmaceuticals, Inc. 2021-10-07 07:55:00 Recursion is Granted FDA Fast Track Designation for REC-2282 for the Potential Treatment of NF2-Mutated Meningiomas

RocketTickers

XENE: Xenon Pharmaceuticals Inc. 2021-10-04 07:00:00 Xenon Pharmaceuticals Announces Positive Topline Results from Phase 2b ‘X-TOLE’ Clinical Trial of XEN1101 for the Treatment of Focal Epilepsy

RocketTickers

ABBV: AbbVie 2021-09-28 18:00:00 FDA Approves QULIPTA™ (atogepant), the First and Only Oral CGRP Receptor Antagonist Specifically Developed for the Preventive Treatment of Migraine

RocketTickers

PFE: Pfizer Inc. 2021-09-29 06:45:00 Positive Top-line Results of Pfizer’s Phase 3 Study Exploring Coadministration of Prevnar 20™ With Seasonal Flu Vaccine in Older Adults Released

RocketTickers

ALT: Altimmune, Inc 2021-09-28 07:01:00 Altimmune Announces Positive Results From 12-week Phase 1 Clinical Trial of ALT-801 (Pemvidutide) in Overweight and Obese Volunteers

RocketTickers

AMGN: Amgen 2021-09-25 20:00:00 FDA Approves Repatha® (evolocumab) In Pediatric Patients Age 10 And Older With Heterozygous Familial Hypercholesterolemia

RocketTickers

TFFP: TFF Pharmaceuticals, Inc. 2021-09-23 08:00:00 TFF Pharmaceuticals Announces Promising Topline Results from Phase 1 Clinical Trial of Inhaled Tacrolimus Powder and Progression Toward Phase 2 in Lung

RocketTickers

PFE: Pfizer Inc. 2021-09-20 06:45:00 Pfizer and BioNTech Announce Positive Topline Results from Pivotal Trial of COVID-19 Vaccine in Children 5 to 11 Years

RocketTickers

SAGE: Sage Therapeutics, Inc. 2021-09-15 06:30:00 Sage Therapeutics Receives Fast Track Designation for SAGE-718 for the Treatment of Huntington’s Disease

RocketTickers

MGTA: Magenta Therapeutics, Inc. 2021-09-15 08:00:00 Magenta Therapeutics Announces IND Clearance for MGTA-117 Targeted Conditioning Clinical Trial

RocketTickers

TBPH: Theravance Biopharma, Inc. 2021-09-15 06:05:00 Theravance Biopharma, Inc. Announces Top-line Results from a Phase 3 Study of Ampreloxetine in Patients with Symptomatic Neurogenic Orthostatic Hypotension

RocketTickers

LIFE: aTyr Pharma, Inc. 2021-09-13 07:30:00 aTyr Pharma Announces Positive Data from Phase 1b/2a Clinical Trial Demonstrating Consistent Dose Response for ATYR1923 in Pulmonary Sarcoidosis

RocketTickers

HOTH: Hoth Therapeutics, Inc. 2021-09-08 08:02:00 Hoth Therapeutics Announces Positive Phase 1b Results for Completed First Cohort of Patient Trial of BioLexa